Caroline le Duigou

Senior Research Scientist at NEURO-SYS

Caroline Le Duigou is a seasoned Senior Research Data Scientist at NEURO-SYS, specializing in project management, customer studies, and R&D solutions since January 2024. Previously, as an R&D Project Manager at MyC MedTech, Caroline collaborated with the AP-HP parasitology department and focused on research tax credit filings. With a strong research background, Caroline served as an AI and Neuroscientist Researcher at AnotherBrain, and a Senior Research Scientist in Neurosciences at ICM - Brain & Spine Institute, contributing to multiple scientific publications and projects in electrophysiology, brain plasticity, and epilepsy. Education includes a PhD in Neurosciences and a Master’s Degree from Pierre and Marie Curie University, alongside recent qualifications in Machine Learning and Data Science.

Location

Paris, France

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


NEURO-SYS

Neuro-Sys is a research-intensive and innovative organisation specialising in pharmacology and in advanced in vitro and in vivo models of neurodegenerative diseases, mode of action research, and drug development in the CNS and PNS fields. We provide pharmacological profiles of lead compounds and explore their underlying mechanism of action and studies to determine the neuroprotective activity. We’re dedicated to providing high-level technical expertise in a collaborative relationship with our clients and accompany you along the drug development stages, from preclinical to clinical. Our expertise: › Alzheimer’s disease (AD) › Parkinson’s disease (PD) › Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease) › Multiple Sclerosis (MS) › Peripheral Neuropathies › Blood Brain Barrier DRUG DEVELOPMENT SERVICES Our experts in drug and pharmaceutical development provide expert guidance on: •The design of your drug discovery development plan (pre-clinical testing in vitro and in vivo models) •The design of your preclinical research programs (in vitro/ in vivo, mode of action) •The preclinical (Pharmacology, PK and ADME) development and early clinical designs (PoC studies) •The writing of research projects, investigator brochures (IB), IMPD, ODD submission (FDA/EMA) in neuro indication


Headquarters

Gardanne, France

Employees

11-50

Links